IS8369A - Aðferð til að hreinsa terbínafín - Google Patents

Aðferð til að hreinsa terbínafín

Info

Publication number
IS8369A
IS8369A IS8369A IS8369A IS8369A IS 8369 A IS8369 A IS 8369A IS 8369 A IS8369 A IS 8369A IS 8369 A IS8369 A IS 8369A IS 8369 A IS8369 A IS 8369A
Authority
IS
Iceland
Prior art keywords
terbinafine
purifying
purifying terbinafine
Prior art date
Application number
IS8369A
Other languages
English (en)
Inventor
Beutler Ulrich
Penn Gerhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8369(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8369A publication Critical patent/IS8369A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IS8369A 2003-08-29 2006-03-23 Aðferð til að hreinsa terbínafín IS8369A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process
PCT/EP2004/009587 WO2005021483A2 (en) 2003-08-29 2004-08-27 Process for the purification of terbinafine

Publications (1)

Publication Number Publication Date
IS8369A true IS8369A (is) 2006-03-23

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8369A IS8369A (is) 2003-08-29 2006-03-23 Aðferð til að hreinsa terbínafín

Country Status (25)

Country Link
US (2) US20060076227A1 (is)
EP (1) EP1694631A2 (is)
JP (1) JP5208416B2 (is)
KR (2) KR101233024B1 (is)
CN (1) CN100491334C (is)
AR (1) AR045506A1 (is)
AU (1) AU2004268051B2 (is)
BR (1) BRPI0413896A (is)
CA (1) CA2536498C (is)
EC (1) ECSP066382A (is)
GB (1) GB0320312D0 (is)
IL (1) IL173709A (is)
IS (1) IS8369A (is)
MA (1) MA28030A1 (is)
MX (1) MXPA06002348A (is)
MY (1) MY149357A (is)
NO (1) NO20061404L (is)
NZ (1) NZ545445A (is)
PE (1) PE20050873A1 (is)
RU (1) RU2367649C2 (is)
SG (1) SG145782A1 (is)
TN (1) TNSN06066A1 (is)
TW (1) TWI350829B (is)
WO (1) WO2005021483A2 (is)
ZA (1) ZA200601264B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
CN102202728A (zh) 2008-09-05 2011-09-28 特拉旺蒂药物股份有限公司 电离子透入药物传送组装结构

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3069633D1 (en) 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1222160B1 (en) 1999-10-22 2003-07-23 Richter Gedeon Vegyeszeti Gyar R.T. Process for preparing a substituted allylamine derivative and the salts thereof
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
GB0320312D0 (en) 2003-10-01
CA2536498C (en) 2012-10-09
KR101233024B1 (ko) 2013-02-13
EP1694631A2 (en) 2006-08-30
AR045506A1 (es) 2005-11-02
BRPI0413896A (pt) 2006-10-24
RU2006109640A (ru) 2007-10-10
TNSN06066A1 (en) 2007-10-03
JP5208416B2 (ja) 2013-06-12
US20060076227A1 (en) 2006-04-13
MXPA06002348A (es) 2006-05-22
IL173709A (en) 2012-02-29
JP2007504110A (ja) 2007-03-01
TW200523231A (en) 2005-07-16
US7985323B2 (en) 2011-07-26
CN100491334C (zh) 2009-05-27
RU2367649C2 (ru) 2009-09-20
AU2004268051B2 (en) 2009-03-05
MA28030A1 (fr) 2006-07-03
CA2536498A1 (en) 2005-03-10
TWI350829B (en) 2011-10-21
SG145782A1 (en) 2008-09-29
PE20050873A1 (es) 2005-11-21
CN1845895A (zh) 2006-10-11
KR20060119892A (ko) 2006-11-24
ZA200601264B (en) 2007-06-27
KR20120054109A (ko) 2012-05-29
WO2005021483A2 (en) 2005-03-10
MY149357A (en) 2013-08-30
US20090216047A1 (en) 2009-08-27
WO2005021483A3 (en) 2005-05-12
NO20061404L (no) 2006-08-25
NZ545445A (en) 2010-03-26
AU2004268051A1 (en) 2005-03-10
ECSP066382A (es) 2006-09-18
IL173709A0 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
IS8122A (is) Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
DE112004000372D2 (de) Destillationsverfahren
NO20055459D0 (no) Prosesser
EP1633321A4 (en) METHOD FOR CLEANING VIRUS
DE602004027332D1 (de) Abgasreinigungskatalysator
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
IS7981A (is) Aðferð til að framleiða örkerfi
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
EP1869230A4 (en) PROCESS FOR PURIFYING PROTEINS
FI20030072A0 (fi) Piiloalueiden poistomenetelmä
FI20060576A (fi) Menetelmiä fenolin puhdistamiseksi
IS7288A (is) Aðferðir til að hreinsa levófloxasín
IS8369A (is) Aðferð til að hreinsa terbínafín
FI20030963A0 (fi) Erotusmenetelmä
NO20035626D0 (no) Metode
DK1817262T3 (da) Forbedret fremgangsmåde til vandrensning
IS8375A (is) Aðferð til að hreinsa prótín framleidd í plöntum
DE602005015492D1 (de) Verbessertes verfahren zur aufreinigung von perindopril
NO20035401D0 (no) Metode
FI20031389A0 (fi) Menetelmä viilun sorvaamiseksi
DE50305832D1 (de) Abgasanlage
DE602004030793D1 (de) Asynchrones flimmerreduktionsverfahren
FR2857975B1 (fr) Procede de disulfuration des essences
GB0327179D0 (en) Purification method
DK1395580T3 (da) Fremgangsmåde til rensning af trizolylmethyloxiraner